Advanced search
Publication Cover
Breast Cancer: Targets and Therapy Volume 12, 2020 - Issue
Submit an article Journal homepage
162
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam

Huyen Thi Phung1 Department of Medical Oncology 6, National Cancer Hospital of Vietnam, Hanoi, Vietnam
,
Hoa Thi Nguyen1 Department of Medical Oncology 6, National Cancer Hospital of Vietnam, Hanoi, Vietnam
,
Tung Van Nguyen1 Department of Medical Oncology 6, National Cancer Hospital of Vietnam, Hanoi, VietnamCorrespondence[email protected]
,
Tai Van Nguyen2 Department of Medical Oncology 1, National Cancer Hospital of Vietnam, Hanoi, Vietnam
,
Lan Anh Thi Dinh3 Department of Optimal Therapy, Quan Su Campus, National Cancer Hospital of Vietnam, Hanoi, Vietnam
&
Chu Van Nguyen4 Department of Pathology, National Cancer Hospital of Vietnam, Hanoi, VietnamORCID Iconhttps://orcid.org/0000-0001-8928-5089
ORCID Icon
Pages 117-122 | Published online: 07 Oct 2020

References

  • AsselainB, BarlowW, BartlettJ, Early Breast Cancer Trialists’ Collaborative G. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol. 2018;19(1):27–39. doi:10.1016/S1470-2045(17)30777-529242041
  • GianniL, EiermannW, SemiglazovV, et al. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort. Lancet. 2010;375(9712):377–384. doi:10.1016/S0140-6736(09)61964-420113825
  • Von MinckwitzG, UntchM, BlohmerJU, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol. 2012;30(15):1796–1804. doi:10.1200/JCO.2011.38.859522508812
  • MieogJS, van der HageJA. Preoperative chemotherapy for women with operable breast cancer. Cochrane Database Syst Rev. 2007;(2):CD005002.17443564
  • ProwellTM, PazdurR. Pathological complete response and accelerated drug approval in early breast cancer. N Engl J Med. 2012;366(26):2438–2441. doi:10.1056/NEJMp120573722646508
  • MarchioC, MalettaF, AnnaratoneL, SapinoA. The perfect pathology report after neoadjuvant therapy. J Natl Cancer Inst Monogr. 2015;2015(51):47–50. doi:10.1093/jncimonographs/lgv01626063886
  • National Comprehensive Cancer Network. Breast cancer; 2018 Available from: https://www.nccn.org. Accessed 822, 2020.
  • BuzdarAU, IbrahimNK, FrancisD, et al. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol. 2005;23(16):3676–3685. doi:10.1200/JCO.2005.07.03215738535
  • Van ThuanT, AnhPT, Van TuD. Cancer control in Vietnam: where are we now?Cancer Control. 2016;99.
  • UntchM, FaschingPA, KonecnyGE, et al. Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups. J Clin Oncol. 2011;29(25):3351–3357. doi:10.1200/JCO.2010.31.493021788566
  • UntchM, RezaiM, LoiblS, et al. Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study. J Clin Oncol. 2010;28(12):2024–2031. doi:10.1200/JCO.2009.23.845120308670

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.